1. Moxalactam (M) or nafcillin and tobramycin (NT) for empiric therapy of febrile granulocytopenic patients;Alanis;22nd Inter science Conference on Antibacterial Agents and Chemotherapy,1987
2. Comparative efficacy and toxicity of moxalactam/piperacillin versus moxalactam/amikacin in febrile granulocytopenic patients;Barnes;22nd Interscience Conference on Antimicrobial Agents and Chemotherapy,1982
3. The role of schedule in antibiotic therapy of the neutropenic patient;Bodey;Infection,1980
4. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli;Clumeck;Scandinavian Journal of Infectious Disease,1982
5. Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms;Clumeck;Antimicrobial Agents Chemotherapy,1983